HMGB3 and central nervous system cancer: CircMMP1 induced proliferation and motility and inhibited the apoptosis of glioma cells by harboring miR-433 to enhance HMGB3 level, thus posing circMMP1/miR-433/HMGB3 axis for glioma therapy [25].